Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› México
Clinical trial register · Mexico

Clinical Trials in México, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1588 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
1588
Studies in scope
all four open statuses
705
Recruiting now
open to new participants
248
Lead sponsors
across recruiting studies
Top sites
Mexico City 600 Monterrey 378 Guadalajara 345 Chihuahua City 177 Mérida 129
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Boehringer Ingelheim9 Hoffmann-La Roche8 Eli Lilly and Company5 Gilead Sciences5 Bristol-Myers Squibb4 Janssen Research & Development, LLC4 Aragon Pharmaceuticals, Inc.3 Novartis Pharmaceuticals3 Merck Sharp & Dohme LLC3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Instituto Nacional de Cancerologia de Mexico2 Coordinación de Investigación en Salud, Mexico2 Actelion2 Amgen2 Novo Nordisk A/S2 Acerta Pharma BV1 EMD Serono Research & Development Institute, Inc.1 Octapharma1 Daiichi Sankyo1 European Organisation for Research and Treatment of Cancer - EORTC1 BeOne Medicines1 H. Lundbeck A/S1 Institut de Recherches Internationales Servier1 ViiV Healthcare1 Show all 32
Site location
Mexico City600 Monterrey378 Guadalajara345 Chihuahua City177 Mérida129 Oaxaca City118 México99 Veracruz93 León88 Aguascalientes85 Culiacán83 San Luis Potosí City74 Cuernavaca70 Puebla City53 Zapopan51 Morelia50 Durango48 Querétaro41 San Pedro Garza García37 Cuauhtémoc33 Tlalpan32 Querétaro City27 Ciudad Madero24 Mexicali24 Tlalnepantla23 Show all 197
All 197 locations
Target enrolment
to

Trials with a site in México

99 of 1588 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Aguascalientes, Chihuahua City, México, Metepec, Guadalajara, Morelia, Monterrey, Oaxaca City
2026-12-16
Not yet open
Eli Lilly and Company
Phase 3
3,000
Actopan, Cuernavaca, Culiacán, Durango, Guadalajara, León, Mexico City, México
2026-12
Recruiting
Bristol-Myers Squibb
Phase 1/2
84
México
2026-10-06
Recruiting
AstraZeneca
Phase 3
2,800
Benito Juárez, Culiacán, Durango, Ecatepec de Morelos, Estado de México, Mexico City, México, Tuxpan
2026-09-01
Recruiting
AstraZeneca
Phase 3
1,072
Guadalajara, México, San Luis Potosí City, Veracruz
2026-08-31
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Guadalajara, México, Monterrey, Querétaro, San Luis Potosí City, Tijuana, Xalapa, Zapopan
2026-08-24
Recruiting
Boehringer Ingelheim
Phase 3
390
Guadalajara, Jalisco, Mexico City, México, Toluca, Zapopan
2026-07-10
Recruiting
Hoffmann-La Roche
Phase 2
30
Torreón, Mexicali, Guadalajara, México, Culiacán
2026-05-25
Recruiting
AstraZeneca
Phase 3
245
Culiacán, Durango, Guadalajara, Mérida, México
2026-04-13
Recruiting
Boehringer Ingelheim
Phase 3
670
Guadalajara, Jalisco, Mexico City, México, Monterrey, Nuevo León, Toluca
2026-04-13
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Col Saucito, Guadalajara, México, Delegacion Cuauhtemoc, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Col Saucito, Guadalajara, Delegacion Cuauhtemoc, México, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-16
Recruiting
Boehringer Ingelheim
Phase 3
400
Jalisco, Mexico City, México, Monterrey
2026-01-16
Recruiting
Coordinación de Investigación en Salud, Mexico
Not applicable
200
México
2025-10-03
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Ciudad Madero, Juriquilla, Mexico City, Mérida, México, Monterrey, Morelia
2025-09-30
Recruiting
BeOne Medicines
Phase 3
500
México, Monterrey, Oaxaca City, Toluca
2025-09-04
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey
2025-07-22
Recruiting
Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children.
NCT07159971Overweight and/or Obesity, Children - Malnutrition, Preventing Malnutrition
Claudia Teresa Tovar Palacio
Not applicable
40
México
2025-06-30
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Aguascalientes, Culiacán, Guadalajara, Irapuato, México, Monterrey, Querétaro, Tijuana
2025-05-20
Active, closed
Boehringer Ingelheim
Phase 1
91
Mexico City, México, Tlajomulco de Zuñiga
2025-05-14
Recruiting
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 2
46
México
2025-05-07
Recruiting
National Institute of Cancerología
Not applicable
80
México
2025-04-02
Recruiting
Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity
NCT06847373Vitamin D, Insulin Resistance, Obesity, Childhood
Coordinación de Investigación en Salud, Mexico
Not applicable
40
México
2025-03-01
Recruiting
Amgen
Phase 3
844
Parques de San Felipe, Mexicali, Guadalajara, Mexico City, Mérida, México
2025-02-25
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Culiacán, Guadalajara, Mexico City, Mexico D F, Mérida, México, Querétaro, San Luis Potosí City
2024-12-04
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Guadalajara, México, Querétaro, San Luis Potosí City
2024-10-07
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Aguascalientes, Torreón, Guadalajara, México, Tlalpan, Cuauhtémoc, Monterrey, Culiacán
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Culiacán, D.F, Guadalajara, Mexico City, México
2024-06-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Aguascalientes, Culiacán, Distrito Federal, Guadalajara, Irapuato, México, Monterrey, Tlalnepantla
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Mexico City, Monterrey, México, Oaxaca City, Querétaro
2024-05-24
Recruiting
Novartis Pharmaceuticals
Phase 3
550
León, Guadalajara, Mexico City, Morelia, Mérida, México
2024-05-21
Recruiting
Octapharma
Phase 3
124
Mexico City, México
2024-04-30
Recruiting
Daiichi Sankyo
Phase 1/2
680
Mérida, México
2024-04-10
Active, closed
Amgen
Phase 3
434
Parques de San Felipe, Torreón Centro, Mexicali, Americana, Mexico City, San Miguel Chapultepec, Centro, México
2024-04-08
Recruiting
AstraZeneca
Phase 3
100
Atizapán de Zaragoza, Guadalajara, Mérida, México, Monterrey
2024-03-14
Active, closed
Boehringer Ingelheim
Phase 3
428
Mexico City, México, Veracruz
2024-02-09
Recruiting
AstraZeneca
Phase 3
625
CD Mexico, Guadalajara, Mexico City, México, Tuxtla Gutiérrez
2023-11-23
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Aguascalientes, México, Guadalajara, Morelia, Oaxaca City, Córdoba, Mérida, Chihuahua City
2023-10-25
Recruiting
AstraZeneca
Phase 3
800
Coyoacán, Culiacán, Guadalajara, Guadalajra, Mexico City, México, Monterrey
2023-09-22
Recruiting
Gilead Sciences
Phase 3
402
Cuernavaca, Irapuato, Mexico City, México, Oaxaca City, Veracruz
2023-09-07
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Saltillo Centro, Zona Urbana Río Tijuana, Zapopan, Monterrey, Culiacán, México
2023-08-28
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Saltillo Centro, Zona Urbana Río Tijuana, Zapopan, Monterrey, Culiacán, México
2023-07-11
Active, closed
Gilead Sciences
Phase 3
654
Cancún, Mexico City, México, Monterrey, Puebla City, San Pedro Garza García, Yucatán
2023-05-08
Active, closed
Novartis Pharmaceuticals
Phase 3
288
León, Guadalajara, Mexico City, Morelia, Mérida, México
2023-04-21
Recruiting
AstraZeneca
Phase 3
4,300
Aguascalientes, Alc. Cuauhtémoc, Colonia Lindavista, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2023-03-31
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Mexico City, Hacienda de Las Palmas, México
2023-03-16
Recruiting
Instituto Nacional de Cancerologia de Mexico
Not applicable
146
México
2023-03-09
Active, closed
AstraZeneca
Phase 3
1,350
Del. Cuauhtemoc, Mexico City, México, San Luis Potosí City
2022-12-29
Active, closed
Gilead Sciences
Phase 3
1,021
México, Mitras Centro, Oaxaca City, Orizaba Centro, Puebla City, Veracruz
2022-10-12
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
381
Cuernavaca, Guadalajara, Mexicali, Mexico City, Mérida, México, Monterrey, Torreón
2022-09-16
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Culiacán, Mérida, México
2022-08-04
Active, closed
Gilead Sciences
Phase 3
443
Chihuahua City, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Chihuahua City, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2022-07-20
Recruiting
Instituto Nacional de Cancerologia de Mexico
Not applicable
33
México
2022-05-19
Active, closed
AstraZeneca
Phase 3
644
CD Mexico, Guadalajara, Guadalajara Jalisco, Mexico City, México
2022-05-16
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Guadalajara, Mexico City, Tlalnepantla, Monterrey, Culiacán, Chihuahua City, México
2022-05-03
Active, closed
Hoffmann-La Roche
Phase 3
208
Mexico City, Monterrey, Distrito Federal, México
2022-04-25
Active, closed
AstraZeneca
Phase 3
760
Guadalajara, Jalisco, México, San Luis Potosí City, Tuxtla Gutiérrez
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Aguascalientes, Culiacán, Guadalajara, Mexico City, México, Oaxaca City, Zapopan
2022-03-25
Active, closed
AstraZeneca
Phase 3
363
Chihuahua City, Guadalajara, México, San Luis Potosí City
2022-02-15
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Guadalajara, León, México, Naucalpan
2021-11-17
Active, closed
Boehringer Ingelheim
Phase 1
151
Mexico City, México, Monterrey
2021-10-18
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Mérida, México, Zapopan
2021-08-25
Recruiting
H. Lundbeck A/S
Phase 3
285
Durango, Guadalajara, Zapopan, Morelia, Monterrey, Culiacán, México, Chihuahua City
2021-06-30
Active, closed
AstraZeneca
Phase 3
367
Chihuahua City, Culiacán, Durango, Guadalajara, Mexicali, Mérida, México
2021-06-08
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Acapulco de Juárez, Guadalajara, Mexico City, Monterrey, San Pedro Garza García, Culiacán, Mérida, México
2021-04-01
Active, closed
Hoffmann-La Roche
Phase 3
751
Mexico City, México, Chihuahua City
2021-03-24
Active, closed
Hoffmann-La Roche
Phase 3
769
Guadalajara, Mexico City, San Luis Potosí City, México
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
985
Mexico City, México, Tialnepantla
2020-10-26
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Chihuahua City, Guadalajara, Mexico City, México, Monterrey, Naucalpan
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Guadalajara, León, Mexico City, México, Monterrey, Naucalpan
2020-09-30
Active, closed
AstraZeneca
Phase 3
866
Alc. Cuauhtémoc, Guadalajara Jalisco, Guadalajra, Mexico City, México, Monterrey, Nuevo León
2020-07-24
Active, closed
Actelion
Phase 3
935
Guadalajara, Mexico City, México, Monterrey, Morelia
2020-06-30
Active, closed
AstraZeneca
Phase 3
805
Aguascalientes, México, Monterrey, Oaxaca City, Querétaro, San Luis Potosí City, Veracruz
2020-05-05
Active, closed
Eli Lilly and Company
Phase 3
58
Chihuahua City, Durango, Guadalajara, México, Monterrey
2020-02-12
Active, closed
Actelion
Phase 3
138
Guadalajara, México, Monterrey
2020-01-16
Active, closed
Sanofi
Observational
1,860
Cuernavaca, Monterrey, México, Puebla City, Tlalnepantla
2019-08-15
Active, closed
AstraZeneca
Phase 3
923
Aguascalientes, Estado de México, Guadalajara, México, Monterrey, Tuxtla Gutiérrez
2019-06-25
Recruiting
Eli Lilly and Company
Phase 3
190
Chihuahua City, Durango, Guadalajara, México, Monterrey
2019-04-05
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
México
2019-03-22
By invitation
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Not applicable
196
México
2019-03-04
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Guadalajara, Monterrey, Santiago de Quetaro, Madero, Chihuahua City, Mexico City, México, Oaxaca City
2018-12-12
Active, closed
AstraZeneca
Phase 3
825
Aguascalientes, Chihuahua City, Guadalajara, México, Monterrey, Pachuca
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Alc. Cuauhtémoc, Culiacán, Guadalajara, Mérida, México, Monterrey, Tuxtla Gutiérrez
2018-11-30
Active, closed
AstraZeneca
Phase 3
407
Culiacán, Mexico City, México, Monterrey, San Luis Potosí City
2018-11-27
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
NCT03549754Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
AstraZeneca
Observational
35,000
León, Iztapalapa, Mexico City, México
2018-02-17
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Culiacán, México
2017-06-26
Active, closed
AstraZeneca
Phase 3
1,186
Aguascalientes, Cuautitlán Izcalli, Guadalajara, Mexico City, México, Monterrey, Tuxtla Gutiérrez
2017-06-01
Active, closed
Acerta Pharma BV
Phase 3
635
Mexico City, México, Monterrey, Querétaro
2017-04-05
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Durango, Guadalajara, León, Mexico City, México, Morelia, Zapopan
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Culiacán, Guadalajara, León, México, Morelia, Zapopan
2015-11-19
Active, closed
AstraZeneca
Phase 3
953
Acapulco, Aguascalientes, Mérida, México, Monterrey
2015-11-03
Active, closed
AstraZeneca
Phase 3
1,126
Guadalajara, León, Mexico City, México, Monterrey
2015-11-02
Active, closed
ViiV Healthcare
Phase 3
371
Chihuahua City, Distrito Federal, Guadajalara, Mexico City, México
2015-02-23
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Chihuahua City, Cuernavaca, Culiacán, México, Oaxaca City, Zapopan
2014-11-26
Active, closed
Eli Lilly and Company
Phase 3
493
Torreón, México, León, Guadalajara, Mexico City, Cuernavaca, Juchitán de Zaragoza, Colinas Del Cimatario
2014-11-06
Active, closed
AstraZeneca
Phase 3
510
México, Monterrey
2013-09-25
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
México
2010-12
Active, closed
AstraZeneca
Phase 3
736
Mexico City, México
2005-02-13
Rows per page Showing 1–99 of 99
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-mexico/city/m-xico

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,588 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 99 of those studies with a site in México.

How many clinical trials are recruiting in México?

40 of the 99 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 56 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (México), 99 studies
PhaseStudiesRecruitingShare
Phase 3792979.8%
Not applicable767.1%
Phase 2525.1%
Observational414%
Phase 1202%
Phase 1/2222%

Most active sponsors

Lead sponsors with the most studies (México)
Lead sponsorStudiesRecruiting
AstraZeneca2710
Boehringer Ingelheim96
Hoffmann-La Roche83
Eli Lilly and Company52
Gilead Sciences51
Bristol-Myers Squibb42
Janssen Research & Development, LLC40
Aragon Pharmaceuticals, Inc.30
Merck Sharp & Dohme LLC31
Novartis Pharmaceuticals31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.